Early Postoperative Intervention in Gastric Cancer Patients
Early Postoperative Structured Intervention for Quality of Life and Prognosis in Gastric Cancer Patients After Neoadjuvant Therapy:: A Multicenter,Open Label Randomized Controlled Trial
1 other identifier
interventional
264
1 country
1
Brief Summary
This study was conducted by Qilu Hospital and five other renowned medical centers, aiming to evaluate the impact of early structured postoperative intervention on quality of life and prognosis in patients with gastric cancer after neoadjuvant therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2026
CompletedStudy Start
First participant enrolled
February 10, 2026
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
March 2, 2026
February 1, 2026
1.1 years
February 10, 2026
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
incidence of complications within 30 days postoperatively
The incidence of complications within 30 days postoperatively was calculated as the number of patients who developed complications within 30 days after surgery divided by the total number of patients in that group.
30 days after operation
Postoperative recovery quality
Postoperative recovery quality was assessed using The 15-item Quality of Recovery Score scale, with a maximum score of 150 points and a minimum score of 0 points, where higher scores indicate better postoperative recovery quality
Baseline (Day of Discharge) and POD 30(30 days after surgery)
Secondary Outcomes (5)
Readmission or emergency department visit rate within 30 days postoperatively
30 days after surgery
Time interval between surgery and initiation of adjuvant chemotherapy
6 month after surgery
Completion rate of postoperative chemotherapy / Adherence to adjuvant chemotherapy
6 month after surgery
Grading of chemotherapy-related adverse events
6 month after surgery
Postoperative quality of life score
Baseline (Day of Discharge) and POD 30(30 days after surgery)
Study Arms (2)
Patients with early structured postoperative intervention
EXPERIMENTALPatients without early structured postoperative intervention
NO INTERVENTIONInterventions
Nutritional intervention: Routine postoperative oral nutritional supplements (ONS) will be provided, and patients with metabolic diseases such as diabetes will undergo strict glycemic control. Psychological intervention: Patients with a Hospital Anxiety and Depression Scale (HADS) score ≥ 8 will receive cognitive behavioral therapy (CBT), and those with a HADS score ≥ 11 will be referred for psychological consultation. Exercise intervention: Postoperative rehabilitation training will be guided according to different postoperative periods.
Eligibility Criteria
You may qualify if:
- Age 18-80 years;
- Histologically confirmed adenocarcinoma by preoperative pathology;
- Completed preoperative neoadjuvant therapy without obvious immune-related adverse events (irAEs);
- Patients with ycT3-4N+Mx disease deemed surgically resectable based on evaluation by gastroscopy, CT, PET-CT, and other imaging modalities;
- Signed informed consent and voluntary participation in this study;
- Standard ERAS (Enhanced Recovery After Surgery) management during the - perioperative period, with postoperative hospital stay ≤7 days.
You may not qualify if:
- Patients with central nervous system diseases or psychiatric disorders;
- Patients with severe diseases of other organ systems;
- Patients with recurrent infectious diseases or severe comorbidities;
- Patients requiring synchronous surgery for other diseases;
- Patients undergoing emergency surgery;
- Patients who developed any complication during hospitalization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Qilu Hospital of Shandong Universitylead
- Linyi People's Hospitalcollaborator
- Liaocheng People's Hospitalcollaborator
- Yantai Yuhuangding Hospitalcollaborator
- Central Hospital of Zibocollaborator
- Weifang People's Hospitalcollaborator
Study Sites (1)
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
Related Publications (5)
Basch E. Patient-Reported Outcomes - Harnessing Patients' Voices to Improve Clinical Care. N Engl J Med. 2017 Jan 12;376(2):105-108. doi: 10.1056/NEJMp1611252. No abstract available.
PMID: 28076708BACKGROUNDGillis C, Ljungqvist O, Carli F. Prehabilitation, enhanced recovery after surgery, or both? A narrative review. Br J Anaesth. 2022 Mar;128(3):434-448. doi: 10.1016/j.bja.2021.12.007. Epub 2022 Jan 7.
PMID: 35012741BACKGROUNDMichard F, Thiele RH, Le Guen M. One small wearable, one giant leap for patient safety? J Clin Monit Comput. 2022 Feb;36(1):1-4. doi: 10.1007/s10877-021-00767-0. Epub 2021 Oct 19. No abstract available.
PMID: 34665392BACKGROUNDTian Y, Cao S, Liu X, Li L, He Q, Jiang L, Wang X, Chu X, Wang H, Xia L, Ding Y, Mao W, Hui X, Shi Y, Zhang H, Niu Z, Li Z, Jiang H, Kehlet H, Zhou Y. Randomized Controlled Trial Comparing the Short-term Outcomes of Enhanced Recovery After Surgery and Conventional Care in Laparoscopic Distal Gastrectomy (GISSG1901). Ann Surg. 2022 Jan 1;275(1):e15-e21. doi: 10.1097/SLA.0000000000004908.
PMID: 33856385BACKGROUNDSauro KM, Smith C, Ibadin S, Thomas A, Ganshorn H, Bakunda L, Bajgain B, Bisch SP, Nelson G. Enhanced Recovery After Surgery Guidelines and Hospital Length of Stay, Readmission, Complications, and Mortality: A Meta-Analysis of Randomized Clinical Trials. JAMA Netw Open. 2024 Jun 3;7(6):e2417310. doi: 10.1001/jamanetworkopen.2024.17310.
PMID: 38888922BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician
Study Record Dates
First Submitted
February 10, 2026
First Posted
March 2, 2026
Study Start
February 10, 2026
Primary Completion (Estimated)
March 10, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
March 2, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning 6 months and ending 36 months following publication
- Access Criteria
- Data will be made available to researchers who provide a methodologically sound proposal, subject to approval by an independent review committee and execution of a data use agreement.
All individual participant data (IPD) underlying the published results